Søren Asger Urhammer

Søren Asger Urhammer serves as a Clinical Associate Professor in the Department of Clinical Medicine within the Faculty of Health and Medical Sciences at the University of Copenhagen. His clinical specialization focuses on Endocrinology, with particular emphasis on Internal Medicine: Endocrinology. He maintains active research and clinical practice at Nordre Fasanvej 57, 2000 Frederiksberg, Copenhagen.

Dr. Urhammer's research centers on endocrinological mechanisms in diabetes pathogenesis, with specific expertise in genetic determinants of insulin secretion and beta-cell function. His work investigates hereditary patterns in type 2 diabetes through family-based studies, examines gene variants affecting insulin receptor pathways, and evaluates pharmacological interventions for diabetes management. His research bridges molecular genetics with clinical endocrinology, particularly in Danish Caucasian populations.

Analysis of his publication record reveals consistent focus on diabetes genetics since the late 1990s, with significant contributions to understanding HNF-1α gene polymorphisms, IRS-2 variants, and PC-1 gene associations. His 2016 Lancet publication on liraglutide therapy demonstrates his transition into clinical trial design for type 1 diabetes complications. The research demonstrates methodological diversity spanning genetic association studies, family-based heritability analyses, and randomized controlled trials.

No scientific awards are explicitly documented in the provided materials. Research impact is evidenced by substantial citation counts across publications, including 143 Scopus citations for his Lancet Diabetes & Endocrinology paper and multiple references in clinical guidelines, policy sources, and patent applications.

Dr. Urhammer collaborates extensively within the University of Copenhagen's diabetes research ecosystem, frequently partnering with prominent researchers including Torben Hansen, Oluf Pedersen, and Christian Tell Ekstrøm. His work shows consistent institutional affiliation with the Department of Clinical Medicine and Copenhagen University Hospital (Region H). While specific laboratory or team structures aren't detailed, his publication patterns indicate participation in large-scale collaborative research groups focused on metabolic disorders.